Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Value
Increase
Decrease
Funds Holding
4,859
Funds Holding Change
+1
Funds Holding Growth
+0%
Value
$1.49T
Holding in Top 10
1,609
Top 10 Change
+328
Top 10 Growth
+26%
Value Growth
-0.4%
New
167
Increased
2,133
Reduced
2,188
Closed
103
Capital Inflow
$62.7B
Capital Outflow
$40.3B
Net Capital Flow
+$22.4B
Capital Flow Change
+$18.1B
Calls
$20.7B
Puts
$17.8B
Net Calls
+$2.84B
Put/Call Ratio
0.86